Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis

Clinical Nephrology

Volumn 75, Issue 1, 2011, Pages 70-73

  Gallieni, M ^a   Chiarelli, G ^a   Olivi, L ^a   Cozzolino, M ^a   Cusi, D ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Candida albicans; Catheter; Fluconazole; Peritoneal dialysis; Peritonitis; Taurolidine; Treatment

Indexed keywords

FLUCONAZOLE; TAUROLIDINE;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; BURNING SENSATION; CANDIDA ALBICANS; CASE REPORT; CATHETER REMOVAL; FUNGAL PERITONITIS; FUNGICIDAL ACTIVITY; HUMAN; MALE; MYCOSIS; PERITONEAL DIALYSIS; PERITONITIS; TREATMENT FAILURE;

ADULT; ANTIFUNGAL AGENTS; CANDIDIASIS; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; DEVICE REMOVAL; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HUMANS; INFUSIONS, PARENTERAL; KIDNEY FAILURE, CHRONIC; MALE; PAIN; PERITONEAL DIALYSIS; PERITONITIS; TAURINE; THIADIAZINES; TREATMENT FAILURE;

EID: 79251524230     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.2379/CNP75070     Document Type: Article

References (10)

1. Prasad N, Gupta A. Fungal peritonitis in peritoneal dialysis patients. Perit Dial Int. 2005; 25: 207-222.
2. Liang CC, Fang JT, Chen KH, Hung CC, Hwang TL, Huang JY. Candida parapsilosis peritonitis complicated with infected pancreatic pseudocysts in a peritoneal dialysis patient: a challenge for nephrologists. Clin Nephrol. 2008; 69: 461-463.
3. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F, Uttley L. ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005; 25: 107-131.
4. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Kawaguchi Y, Piraino B, Riella M, Vas S. International Society for Peritoneal Dialysis. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int. 2000; 20: 396-411. Erratum in: Perit Dial Int. 2000; 20: 828-829.
5. Blenkharn JI. The antibacterial and antiendotoxin activity of Taurolidine in combination with antibiotics. Surg Res Commun. 1987; 2: 149-155.
6. Gorman SP, McCafferty DF, Woolfson AD, Junes DS. Electron microscope observations of bacterial cell surface effects due to taurolidine treatment. Lett Appl Microbiol. 1987; 4: 103-109.
7. Percival SL, Kite P. Intravascular catheters and biofilm control. J Vasc Access. 2007; 8: 69-80.
8. Jones DS, Gorman SP, McCafferty DF, Woolfson AD. The effects of three non-antibiotic, antimicrobial agents on the surface hydrophobicity of certain micro-organisms evaluated by different methods. J Appl Bacteriol. 1991; 71: 218-227.
9. Branger B, Marion K, Bergeron E, Perret C, Zabadani B, Reboul P, Freney J. Using detachment-promoting agents for the prevention of chronic peritoneal dialysis-associated infections. Artif Organs. 2008; 32: 918-924.
10. Gong L, Greenberg HE, Perhach JL,Waldman SA, Kraft WK. The pharmacokinetics of taurolidine metabolites in healthy volunteers. J Clin Pharmacol. 2007; 47: 697-703.